ERBB2 and breast cancer: Comparative genomic hybridization arrays and fluorescence in situ hybridization (FISH) studies have shown that HER2-amplified breast cancers present a variety of alterations on Chr17 and gene amplifications at Chr17q12-q21 are particularly frequent and complex [5].